The study reaffirms Digexin's substantial benefits for GI health, mood, stress reduction, and quality of life while pointing to a novel brain-to-gut mechanism.

Successful completion of clinical study enrollment paves way for next phase of BARDA funding. Data used to finalize DeepView AI®-Burn algorithm.

Data from the study to support regulatory submissions on track for 2023. Participation from distinguished EU principal investigators provides significant endorsement for DeepView™.

The Largest Clinical and Commercial Hemp and CBD Education Event

This study was created to help women Find Relief from Endometriosis and Exclusion (FREE HER). Its purpose is to help us learn how medications and other substances can reduce complaints of pelvic pain and related issues.

OliLux Biosciences is partnering with the R2D2 TB Network and the UCSF Center for Tuberculosis to clinically evaluate and advance its novel rapid detection technology for drug-resistant tuberculosis.

● Faro Health Inc. strengthens its management team, appointing Kimberly C. Pospahala as Vice President of Commercial to accelerate go-to-market efforts to digitally transform clinical protocol design ● Scott Chetham, Ph.D., Co-Founder & CEO of Faro Health, Inc., will present at the SCOPE Conference on Feb. 9, 2022

Former KCI (Acelity), 3M and Siemens Healthcare Vice President Nils Windler joins Spectral MD

Data being collected from 150 adult subjects to further develop DeepView® DFU application

92% for adults and 88% for pediatric accuracies reported on 124 subject multi-center clinical study

Nidlegy was found to be well-tolerated and 149 out of the anticipated 214 patients have been safely treated. Data Safety Monitoring Board recommends to continue the study as planned.

Bring your own device (BYOD) solutions offer a disruptive alternative to the costly provisioned solutions for ePRO but have been mostly overlooked and only moderately considered due, in part, to this question of equivalence and to concerns for patients accepting study tools on their own phones.

Experts from Comprehend and Tufts CSDD to discuss the recent study, outline where the industry is headed and ways to overcome oversight challenges including transparency, risk, and compliance